In line with our results, a recent evidence-based international consensus statement on venous thromboprophylaxis stated that “there is insufficient data to demonstrate superiority for one Factor Xa inhibitor over another as venous thromboembolism (VTE) prophylaxis”, regarding efficacy and the safety profile [26]. Here, F10 is linked to venous thromboembolism.